{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:20:34Z","timestamp":1790832034988,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P016006\/1"],"award-info":[{"award-number":["MR\/P016006\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S015116\/1"],"award-info":[{"award-number":["MR\/S015116\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["HICF 107572"],"award-info":[{"award-number":["HICF 107572"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007423","name":"Duchenne Parent Project","doi-asserted-by":"publisher","award":["ERC-2019-ADG 884952"],"award-info":[{"award-number":["ERC-2019-ADG 884952"]}],"id":[{"id":"10.13039\/501100007423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cell therapy for muscular dystrophy has met with limited success, mainly due to the poor engraftment of donor cells, especially in fibrotic muscle at an advanced stage of the disease. We developed a cell-mediated exon skipping that exploits the multinucleated nature of myofibers to achieve cross-correction of resident, dystrophic nuclei by the U7 small nuclear RNA engineered to skip exon 51 of the dystrophin gene. We observed that co-culture of genetically corrected human DMD myogenic cells (but not of WT cells) with their dystrophic counterparts at a ratio of either 1:10 or 1:30 leads to dystrophin production at a level several folds higher than what predicted by simple dilution. This is due to diffusion of U7 snRNA to neighbouring dystrophic resident nuclei. When transplanted into NSG-mdx-\u039451mice carrying a mutation of exon 51, genetically corrected human myogenic cells produce dystrophin at much higher level than WT cells, well in the therapeutic range, and lead to force recovery even with an engraftment of only 3\u20135%. This level of dystrophin production is an important step towards clinical efficacy for cell therapy.<\/jats:p>","DOI":"10.1038\/s44321-024-00031-3","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T10:01:51Z","timestamp":1709546511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of\u00a0Duchenne Muscular Dystrophy"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6696-4086","authenticated-orcid":false,"given":"Francesco","family":"Galli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laricia","family":"Bragg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8199-4999","authenticated-orcid":false,"given":"Maira","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8616-3377","authenticated-orcid":false,"given":"Laura","family":"Perani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0213-2328","authenticated-orcid":false,"given":"Marco","family":"Bacigaluppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6060-8208","authenticated-orcid":false,"given":"Rossana","family":"Tonlorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tendai","family":"Sibanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Caffarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3614-5848","authenticated-orcid":false,"given":"Avraneel","family":"Talapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Santoleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Meregalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-9943","authenticated-orcid":false,"given":"Beatriz","family":"Bano-Otalora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0337-5425","authenticated-orcid":false,"given":"Anne","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3485-8537","authenticated-orcid":false,"given":"Irene","family":"Bozzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2705-3984","authenticated-orcid":false,"given":"Yvan","family":"Torrente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5863-9593","authenticated-orcid":false,"given":"Giulio","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"issue":"8","key":"31_CR2","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/s41591-021-01467-7","volume":"27","author":"C Arnold","year":"2021","unstructured":"Arnold C (2021) Record number of gene-therapy trials, despite setbacks. Nat Med 27(8):1312\u20131315","journal-title":"Nat Med"},{"key":"31_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.stem.2007.09.016","volume":"1","author":"R Benchaouir","year":"2007","unstructured":"Benchaouir R, Meregalli M, Farini A, D\u2019Antona G, Belicchi M, Goyenvalle A, Oyenvalle A, Battistelli M, Bresolin N, Bottinelli R et al (2007) Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 1:646\u2013657","journal-title":"Cell Stem Cell"},{"issue":"11","key":"31_CR4","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1172\/JCI142031","volume":"130","author":"S Biressi","year":"2020","unstructured":"Biressi S, Filareto A, Rando T (2020) Stem cell therapy for muscular dystrophies. J Clin Invest 130(11):5652\u20135664","journal-title":"J Clin Invest"},{"key":"31_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Roy AJ, Chamova T et al (2015) The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Human Mutation 36:395\u2013402","journal-title":"Human Mutation"},{"issue":"10123","key":"31_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0140-6736(17)31366-1","volume":"391","author":"G Cossu","year":"2018","unstructured":"Cossu G, Birchall M, Brown T, De Coppi P, Culme-Seymour E, Gibbon S, Hitchcock J, Mason C, Montgomery J, Morris S et al (2018) Lancet Commision: Stem cells and regenerative medicine. Lancet 391(10123):883\u2013910","journal-title":"Lancet"},{"key":"31_CR7","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.15252\/emmm.201505636","volume":"7","author":"G Cossu","year":"2015","unstructured":"Cossu G, Previtali SC, Napolitano S, Cicalese MP, Tedesco FS, Nicastro F, Noviello M, Roostalu U, Natali Sora MG, Scarlato M et al (2015) Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy. EMBO Mol Med 7:1513\u20131528","journal-title":"EMBO Mol Med"},{"key":"31_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nrm2024","volume":"7","author":"KE Davies","year":"2006","unstructured":"Davies KE, Nowak KJ (2006) Molecular mechanisms of muscular dystrophies: old and new players. Nat Rev Mol Cell Biol 7:762\u2013773","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"14","key":"31_CR1","doi-asserted-by":"publisher","first-page":"9456","DOI":"10.1073\/pnas.142302299","volume":"99","author":"FG De Angelis","year":"2002","unstructured":"De Angelis FG, Sthandier O, Berarducci B, Toso S, Galluzzi G, Ricci E, Cossu G, Bozzoni I (2002) Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells. Proc Natl Acad Sci USA 99(14):9456\u20139461","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"31_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/oxfordjournals.bmb.a072350","volume":"45","author":"JT Den Dunnen","year":"1989","unstructured":"Den Dunnen JT, Bakker E, van Ommen GJ, Pearson PL (1989) The DMD gene analysed by field inversion gel electrophoresis. Br Med Bull 45(3):644\u2013658","journal-title":"Br Med Bull"},{"issue":"10","key":"31_CR9","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","volume":"26","author":"D Duan","year":"2018","unstructured":"Duan D (2018) Systemic AAV micro-dystrophin gene therapy for Duchenne Muscular Dystrophy. Mol Ther 26(10):2337\u20132356","journal-title":"Mol Ther"},{"issue":"3","key":"31_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ncb2164","volume":"13","author":"JA Efe","year":"2011","unstructured":"Efe JA, Hilcove S, Kim J, Zhou H, Ouyang K, Wang G, Che J, Ding S (2011) Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol 13(3):215\u2013222","journal-title":"Nat. Cell Biol"},{"key":"31_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","volume":"359","author":"AE Emery","year":"2002","unstructured":"Emery AE (2002) The muscular dystrophies. Lancet 359:687\u2013695","journal-title":"Lancet"},{"issue":"12","key":"31_CR13","doi-asserted-by":"publisher","first-page":"e81302","DOI":"10.1371\/journal.pone.0081302","volume":"8","author":"RS Finkel","year":"2013","unstructured":"Finkel RS, Flanigan KM, Wong B, B\u00f6nnemann C, Sampson J, Sweeney HL, Reha A, Northcutt VJ, Elfring G, Barth J et al (2013) Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy. PLoS ONE 8(12):e81302","journal-title":"PLoS ONE"},{"key":"31_CR14","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1089\/hum.2018.151","volume":"29","author":"F Galli","year":"2018","unstructured":"Galli F, Bragg L, Meggiolaro L, Rossi M, Caffarini M, Naz N, Santoleri S, Cossu (2018) Gene and cell therapy for muscular dystrophies: are we getting there? Hum Gene Ther 29:1098\u20131105","journal-title":"Hum Gene Ther"},{"key":"31_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.15252\/emmm.201607199","volume":"9","author":"C Godfrey","year":"2017","unstructured":"Godfrey C, Desviat LR, Smedsrod B, Pietri-Rouxel F, Denti MA, Disterer P, Lorain S, Nogales-Gadea G, Sardone V, Anwar R et al (2017) Delivery is key: lessons learnt from developing splice-switching antisense therapies. EMBO Mol Med 9:545\u2013557","journal-title":"EMBO Mol Med"},{"issue":"15","key":"31_CR16","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1093\/hmg\/ddv155","volume":"24","author":"C Godfrey","year":"2015","unstructured":"Godfrey C, Muses S, McClorey G, Wells KE, Coursindel T, Terry RL, Betts C, Hammond S, O\u2019Donovan L, Hildyard J et al (2015) How much dystrophin is enough: the physiological consequences of different level of dystrophin in the mdx mouse. Hum Mol Genet 24(15):4225\u20134237","journal-title":"Hum Mol Genet"},{"issue":"6","key":"31_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne Muscular Dystrophy Locus. Cell 51(6):919\u2013928","journal-title":"Cell"},{"issue":"4","key":"31_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3233\/JND-150116","volume":"2","author":"A Hotta","year":"2015","unstructured":"Hotta A (2015) Genome Editing Gene therapy for Duchenne Muscular Dystrophy. J Neuromuscul Dis 2(4):343\u2013355","journal-title":"J Neuromuscul Dis"},{"issue":"10","key":"31_CR19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S1474-4422(09)70211-X","volume":"8","author":"M Kinali","year":"2009","unstructured":"Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Ashton E, Abbs S, Nihoyannopoulos P et al (2009) Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol 8(10):918\u2013928","journal-title":"Lancet Neurol"},{"key":"31_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jneuroim.2008.06.026","volume":"201-202","author":"M Kinali","year":"2008","unstructured":"Kinali M, Beeson D, Pitt MC, Jungbluth H, Simonds AK, Aloysius A, Cockerill H, Davis T, Palace J, Manzur AY et al (2008) Congenital myasthenic syndrome in childhood: diagnostic and management challenges. J Neuroimmunol 201-202:6\u201312","journal-title":"J Neuroimmunol"},{"issue":"3","key":"31_CR21","first-page":"184","volume":"31","author":"W Klingler","year":"2012","unstructured":"Klingler W, Jurkat-Rott K, Lehmann-Horn F, Schleip R (2012) The role of fibrosis in Duchenne muscular dystrophy. Acta Myol 31(3):184\u2013195","journal-title":"Acta Myol"},{"issue":"10","key":"31_CR22","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1172\/JCI1505","volume":"101","author":"L Lattanzi","year":"1998","unstructured":"Lattanzi L, Salvatori G, Coletta M, Sonnino C, Cusella De Angelis MG, Gioglio L, Murry CE, Kelly R, Ferrari G et al (1998) High efficency myogenic conversion of human fibroblast by adenoviral vectro-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J Clin Invest 101(10):2119\u20132128","journal-title":"J Clin Invest"},{"issue":"13","key":"31_CR23","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1056\/NEJMoa2307798","volume":"389","author":"A Lek","year":"2023","unstructured":"Lek A, Wong B, Keeler A, Blackwood M, Ma K, Huang S, Sylvia K, Batista AR, Artinian R, Kokoski D et al (2023) Death after High-Dose rAAV9 gene therapy in a patient with Duchenne\u2019s Muscular Dystrophy. N Engl J Med 389(13):1203\u20131210","journal-title":"N Engl J Med"},{"key":"31_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-1-34","volume":"1","author":"K Mamchaoui","year":"2011","unstructured":"Mamchaoui K, Trollet C, Bigot A, Negroni E, Chaouch S, Wolff A, Kandalla PK, Marie S, Di Santo J, Guilly JL et al (2011) Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders. Skeletal Muscle 1:34","journal-title":"Skeletal Muscle"},{"issue":"3","key":"31_CR25","doi-asserted-by":"publisher","first-page":"e17454","DOI":"10.1371\/journal.pone.0017454","volume":"6","author":"J Meng","year":"2011","unstructured":"Meng J, Adkin CF, Xu S, Muntoni F, Morgan JE (2011) Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice. PLoS ONE 6(3):e17454","journal-title":"PLoS ONE"},{"key":"31_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","volume":"2","author":"F Muntoni","year":"2003","unstructured":"Muntoni F, Torelli S, Ferlini A (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2:731\u2013740","journal-title":"Lancet Neurol"},{"key":"31_CR27","first-page":"9 25 21","volume":"83","author":"BR Nallamilli","year":"2014","unstructured":"Nallamilli BR, Ankala A, Hegde M (2014) Molecular diagnosis of duchenne muscular dystrophy. Curr Protoc Hum Genet 83:9 25 21\u201329 25 29","journal-title":"Curr Protoc Hum Genet"},{"issue":"6203","key":"31_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/337176a0","volume":"337","author":"TA Partridge","year":"1989","unstructured":"Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM (1989) Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337(6203):176\u2013179","journal-title":"Nature"},{"issue":"6413","key":"31_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/361647a0","volume":"361","author":"T Ragot","year":"1993","unstructured":"Ragot T, Vincent N, Chafey P, Vigne S, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan JC, Perricaudet M et al (1993) Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361(6413):647\u2013650","journal-title":"Nature"},{"key":"31_CR30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nature05282","volume":"444","author":"M Sampaolesi","year":"2006","unstructured":"Sampaolesi M, Blot S, D\u2019Antona G, Granger N, Tonlorenzi R, Innocenzi A, Mognol P, Thibaud JL, Galvez BG, Barthelemy I et al (2006) Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444:574\u2013579","journal-title":"Nature"},{"key":"31_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1126\/science.1082254","volume":"301","author":"M Sampaolesi","year":"2003","unstructured":"Sampaolesi M, Torrente Y, Innocenzi A, Tonlorenzi R, D\u2019Antona G, Pellegrino MA, Barresi R, Bresolin N, De Angelis MG, Campbell KP et al (2003) Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301:487\u2013492","journal-title":"Science"},{"issue":"6271","key":"31_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar M, Zhu K, Cheng JKW, Chew WL, Widrick JJ, Yan WX, Maesner C, Wu EY, Xiao R, Ran FA et al (2016) In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351(6271):407\u2013411","journal-title":"Science"},{"issue":"140","key":"31_CR33","doi-asserted-by":"publisher","first-page":"140ra89","DOI":"10.1126\/scitranslmed.3003541","volume":"4","author":"FS Tedesco","year":"2012","unstructured":"Tedesco FS, Gerli MF, Perani L, Benedetti S, Ungaro F, Cassano M, Antonini S, Tagliafico E, Artusi V, Longa E et al (2012) Transplantation of genetically corrected humaniPSC-derived progenitors in mice with lim-girdle muscular dystrophy. Sci Transl Med 4(140):140ra89","journal-title":"Sci Transl Med"},{"issue":"96","key":"31_CR34","doi-asserted-by":"publisher","first-page":"96ra78","DOI":"10.1126\/scitranslmed.3002342","volume":"3","author":"FS Tedesco","year":"2011","unstructured":"Tedesco FS, Hoshiya H, D\u2019Antona G, Gerli MF, Messina G, Antonini S, Tonlorenzi R, Benedetti S, Berghella L, Torrente Y et al (2011) Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy. Sci Transl Med 3(96):96ra78","journal-title":"Sci Transl Med"},{"key":"31_CR35","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1126\/science.6729462","volume":"224","author":"R Worton","year":"1984","unstructured":"Worton R, Duff C, Sylvester JE, Schmickel RD, Willard H (1984) Duchenne muscular dystrophy involving translocation of the dmd gene next to ribosomal RNA genes. Science 224:1447\u20131449","journal-title":"Science"}],"updated-by":[{"DOI":"10.1038\/s44321-024-00134-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000}}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-024-00031-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:31:19Z","timestamp":1785853879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-024-00031-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,15]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1038\/s44321-024-00031-3","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s44321-024-00134-x","URL":"https:\/\/doi.org\/10.1038\/s44321-024-00134-x","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests. Prof Giulio Cossu is an Editorial Advisory Board Member. This has no bearing on the editorial consideration of this article for publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"19"}}